PATIENT MONITORING (ADVANCED)

Mindray BeneVision™
N19 | 22” Monitor

Logo of leading global medical equipment and solutions supplier with a deep focus on healthcare distributed by RCA in South Africa
Logo of leading global medical equipment and solutions supplier with a deep focus on healthcare distributed by RCA in South Africa

Product Description

BeneVision™ N19/N22 is designed to optimize user experience by satisfying all your clinical demands. With visionary-stimulating design, benchmarking ease of use, confidence-maximizing innovations and workflow-transforming interoperability, BeneVision N19/N22 is creating tomorrow’s monitoring perspective today.

  • A seamless outlook optimizes your monitoring experience with a super large touchscreen
  • Rotatable landscape & portrait layout
  • Ultra slim main unit as well as plug-n-play modules
  • An ingenious user interface including multi-window flat menus
  • Cutting-edge clinical measurements, such as rSO2, ICG, PiCCO, AG, RM, BIS, NMT
  • State-of-art clinical decision support tools, such as HemoSightTM, ST GraphicTM, DSA
  • Infographic alarm indications
  • Online user guide offers extremely intuitive patient data and ultimate ease-of-use
  • The connectivity capabilities of BeneVision N19/N22 fit seamlessly into your clinical workflow for a paperless future.
  • Revolutionary iView clinical informatics workstation brings all intelligence (PACS, LIS, EMR, etc) on screen at point of care for one-stop diagnosis.
  • Industry-leading BeneLink integrates all bedside devices to the monitor realtimely and facilitates centralized data management.

Interested in the N19 / N22 patient monitor?

Connect with our Team

Contact our sales team

How can we help you? Complete the form below and our sales team will be happy to assist.

"*" indicates required fields

By submitting this form you agree to our terms and conditions and our Privacy Policy which explains how we may collect, use and disclose your personal information including to third parties.
This field is for validation purposes and should be left unchanged.